Updated hourlyHourly refreshSun, Nov 1, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Biotech & pharma
NEW YORK, Oct. 28, 2026 -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023 and August 7, 2026, both dates inclusive (the "Class...
Oct 28 · 20:15·PR Newswire
Finance
CLEVELAND, Oct. 28, 2026 -- Preformed Line Products Company (NASDAQ: PLPC) today reported financial results for its third-quarter of 2026. Q3 2026 highlights: Quarterly net sales of $209.5 million, an increase of 18% from Q3 2025. Quarterly gross profit margin of 33.4%, up...
Oct 28 · 20:15·PR Newswire
Finance · Banking
BIRMINGHAM, Ala., Oct. 28, 2026 -- First US Bancshares, Inc. (Nasdaq: FUSB) (the "Company"), the parent company of First US Bank (the "Bank"), today reported net income of $2.0 million, or $0.36 per diluted share, for the quarter ended September 30, 2026 ("3Q2026"), compared...
Oct 28 · 20:15·PR Newswire
Finance
Funding provides up to $11 million for Mackenzie sawmill modernization
Funding provides up to $11 million for Mackenzie sawmill modernization
Oct 28 · 20:15·GlobeNewswire
Finance · Banking
SOUDERTON, Pa., Oct. 28, 2026 -- Univest Financial Corporation (“Univest” or the "Corporation") (NASDAQ: UVSP), parent company of Univest Bank and Trust Co. (the "Bank") and its insurance, investments and equipment financing subsidiaries, announced net income for the quarter ended September 30, 2026 of $21.6 million, or $0.78 diluted earnings per share, compared to net income of $25.6 million, or $0.89 diluted earnings per share, for the quarter ended September 30, 2025, primarily due to an increase in provision for credit losses during the quarter associated with elevated charge-offs.
Oct 28 · 20:15·GlobeNewswire
Finance
NEENAH, WI, Oct. 28, 2026 -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal fourth quarter and fiscal year ended October 3, 2026, and guidance for our fiscal first quarter ending January 2, 2027.
Oct 28 · 20:15·GlobeNewswire
Finance · Banking
RUSTON, La., Oct. 28, 2026 -- Origin Bancorp, Inc. (TXSE: OBK) (“Origin,” “we,” “our” or the “Company”), the holding company for Origin Bank (the “Bank”), today announced net income of $37.8 million, or $1.22 diluted earnings per share (“EPS”), for the quarter ended September 30, 2026, compared to net income of $33.8 million, or $1.09 diluted EPS, for the quarter ended June 30, 2026. Pre-tax, pre-provision (“PTPP”)(1) earnings were $50.7 million for the quarter ended September 30, 2026, compared to $43.2 million for the linked quarter.
Oct 28 · 20:15·GlobeNewswire
Finance
` - Quarterly Revenue of $385.9 Million, up 39% Year-over-Year -
- Quarterly Net Income of $28.7 Million, up 93% Year-over-Year -
- Quarterly Adjusted EBITDA of $62.2 Million, up 73% Year-over-Year -
- Record Quarterly Monthly-Active-Users in North America -
- Reiterating Full Year 2026 Revenue and Adjusted EBITDA Guidance -
Oct 28 · 20:15·GlobeNewswire
Finance
EXTON, Pa., Oct. 28, 2026 --
Dean W. Rivest, Chief Executive Officer of Omega Flex, Inc. (the “Company”), announced that net sales of the Company for the nine months ended September 30, 2026 and 2025 were $72,847,000 and $73,089,000, respectively, decreasing by $242,000 or 0.3%. Net sales for the three months ended September 30, 2026 were 6.0% higher than net sales for the three months ended September 30, 2025.
Oct 28 · 20:15·GlobeNewswire
Finance · Banking
RUSTON, La., Oct. 28, 2026 -- Origin Bancorp, Inc. (NYSE: OBK) ("Origin"), the holding company for Origin Bank, today announced that on October 28, 2026, its board of directors declared a quarterly cash dividend of $0.28 per share of its common stock. The cash dividend will be paid on November 30, 2026, to stockholders of record as of the close of business on November 13, 2026.
Oct 28 · 20:15·GlobeNewswire
Finance · Healthcare
CAMBRIDGE, Mass., Oct. 28, 2026 -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that it awarded inducement grants on October 26, 2026, to its Executive Vice President and Chief Medical Officer, Jing Marantz, M.D., Ph.D., as a material inducement to employment.
Oct 28 · 20:15·GlobeNewswire
Finance · Energy
Third-quarter 2026 earnings call and webcast are Thursday, November 5
Third-quarter 2026 earnings call and webcast are Thursday, November 5
Oct 28 · 20:15·GlobeNewswire